Context: Germany and Switzerland have introduced diagnosis-related groups (DRGs) for hospital reimbursement.
tematic review analyzed mortality, readmission, discharge destination, severity of illness, and volume of care and found that results were very variable with no overall effect on mortality, readmission to hospital, or volume of care.
Authors note an increase in reported severity of illness and in the Unites States a higher probability under DRG to be admitted to postacute care. From a total of 16 565 studies screened, only 65 were eligible, out of which 50 came from the United States. Only 4 studies from Germany and Switzerland fulfilled inclusion criteria. [11] [12] [13] [14] In Germany, Reinhold and colleagues 15 provided the first overview on the impact of DRG introduction. Their review focused on its economic consequences and concluded that length of stay and reimbursements were reduced under the DRG payment model. Prior to the introduction of DRG in Switzerland, Brügger conducted a scoping review in 2010 on the international experience of DRG with regard to 3 outcomes: health care costs, quality of care, and access to care. He found neither evidence for positive effects (eg, with regard to cost containment) nor evidence for negative effects (eg, reduction of quality of care). 16 In both Switzerland and Germany, public discussions on the possible impact on the health care system accompanied the introduction of DRG. 3, [17] [18] [19] However, the extent to which these concerns are grounded in evidence is unclear. Furthermore, SwissDRG is an adaption of the German G-DRG. Few German and Swiss studies were included in the 2014 international systematic review, 10 and only 1 review has been done to date on G-DRG. 15 In light of the similarities between Swiss-DRG and G-DRG, both countries were included in this scoping review.
This scoping review seeks to provide an overview of the empirical evidence that exists on any change due to the introduction of DRG reimbursement in Germany and Switzerland. Diagnosis-related group introduction affects the interface between administration, economy, and health care, and as such, many study designs are feasible to evaluate the effects. The scoping review methodology allows us to include a wide variety of studies and present a comprehensive overview of the current evidence on DRG introduction in Germany and Switzerland. Our aim is to include and evaluate any empirical evidence on the impact of DRG introduction to inform researchers, health care professionals, and policy makers on the current state of knowledge. The methodology allows us to include by far more studies than the recent international systematic review and meta-analysis, 10 and we are able to update earlier reviews conducted in Germany or in Switzerland.
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The following research questions shall be answered:
• What types of scientific publications are most frequent on DRG introduction in Germany and Switzerland?
• Which study designs and outcomes were applied to investigate possible changes due to DRG introduction in Germany and Switzerland?
• What is the empirical evidence for changes due to DRG introduction in German and Swiss hospitals?
| METHODS
We adapted a standard 5-step scoping review framework outlined in literature [20] [21] [22] [23] : define a research question, search literature, select studies, chart studies, and summarize studies. We did not include an optional consultation.
Because G-DRG began in 2004, the starting time point for our literature was selected as 2003. We consulted university librarians on our search strategy. We systematically searched for literature in Medline via PubMed, Embase (Elsevier), CINAHL, PsychINFO, and Psyndex. English, French, and German articles were included. • Not relevant to the impact of DRG.
• Outside the regional scope of Germany and/or Switzerland.
• DRG as mere selection criteria or an argument to conduct a study on/analyze other themes (management, nursing workload etc.).
• Exclusively about refinement of DRG coding or development of adequate codes/groups.
• Studies on psychiatry (different reimbursement system).
Articles were then categorized into editorials/comments, reviews, and empirical studies. Only studies that collected and analyzed empirical data on DRG introduction were included for full-text extraction. Quantitative as well as qualitative studies were eligible.
Three authors (IK, KN, and TW) carried out the full-text extraction using a data extraction sheet. First, researchers verified that articles fulfilled the inclusion criteria and presented original empirical data. Next, we extracted data on geographic area, type of hospital (size, funding), research question/aims of the study, outcome measures, study design, methodology, collected data, data analysis, study duration, study population, comparison group, important results, and study conclusions. Taking into account the wide variety of included studies, our data extraction sheet included several open questions, such as the following:
• Outcome measures (Which primary and secondary outcome measures were described in the methods section?)
• Important results (max. 4 bullet points for qualitative studies; described data for primary and secondary outcome measure for quantitative studies)
• Key conclusion of study authors (Please describe in max. three bullet points the authors' conclusion.)
Data on country, study design, collected data, study population, specialty, comparison group, and outcome measures were summarized in an Excel sheet. To give an overview of results considering the presumed heterogeneity of study populations, specialties, and outcome parameters, a narrative summary of results and conclusions is provided.
| RESULTS
A total of 1944 references were retrieved from the included databases. After exclusion of duplicates, 1405 references were included in the abstract screening ( Figure 1 ). During this stage, 1239 abstracts were excluded. Based on the abstract screening, 82 abstracts were rated as comments/editorials or review articles and hence were excluded from the full-text screening. A total of 84 articles were included in the full-text analysis. Two articles were added from screening the reference lists of 82 of nonempirical articles on DRG, making a total of 86 articles for the full-text analysis. From this, 41 articles could be included in our final analysis. The remaining 45 articles were excluded after full-text review as they did not meet our predefined exclusion criteria or they did not collect and analyze empirical data on DRG introduction in Switzerland and/or Germany.
| Types of publication
Altogether 135 articles were found on DRG, including 82 editorials/comments and reviews, 12 articles from the 45 excluded full texts not presenting empirical research, and 41 included articles on DRG presenting empirical research.
Overall, 30.4% (41 of 135) of the identified articles presented empirical data. Our sample contained 2 publications each from 5 empirical research projects, meaning that 41 full texts were based on 36 different datasets.
| Overview study design and outcomes
All included studies used a quantitative methodology for data collection and analysis. Table 2 shows the distribution with regard to the 2 countries, study design, collected data, study group, specialty, comparison group, and outcome parameters. For our analysis, publications based on the same data set were only counted once (n = 36).
Most studies used register data (21 of 36, 58.3%), and other studies used data from surveys and/or medical records. One publication presented a secondary analysis of a dataset from a clinical trial. A total of 29 studies (80.6%) were based on German data, and 7 studies included data (19.4%) from Switzerland.
The majority of studies compared data from different groups: 27 studies (75.0%) compared data over time for a specific population, eg, before and after DRG introduction. Three studies (8.3%) were done in Switzerland and had a parallel control group. The remaining 6 studies (16.7%) were cross-sectional surveys with no comparative control group.
We found a large number of different outcome parameters extracting data from the publications ( Table 2 ). The most frequently used outcome parameters were length of stay (LOS) (12) , reimbursement/cost (9), and number of cases (9).
| Synthesis of evidence on the impact of DRG introduction in Germany and Switzerland
We identified themes which might be affected by DRG introduction and were investigated in the included studies:
patient care, case numbers/distribution, health care professionals, patient satisfaction, and reimbursement.
Effects on patient care were analyzed by a number of studies. Most of these studies found a significant decrease of LOS under DRG, [11] [12] [13] [14] 32, 34, 49, 55, 58 but a few found no changes. 51, 56, 63 With regard to other observed patient care
outcomes, results were rather heterogeneous. For example, 1 study found a slight decrease of improvement along rehabilitation after DRG introduction. 51 Another study with a parallel comparative design pointed out a better discharge process, higher patient satisfaction, and lower rehospitalization rates in DRG hospitals. 55 There was also a study finding no changes at all regarding patient care. 56 One study, investigating stroke care in Germany between 2003 and 2006, pointed out that stroke care had significantly reduced the severity of stroke on admission within this period of time; thus, an attribution of changes to the 2 parallel events DRG introduction and changes in stroke management was impossible.
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Several studies focused on the effects of DRG introduction on case distribution among hospitals or effects on the number of cases treated. Most of these studies found an increase in volume of cases treated over the years. 28, 33, 34, 46 An exception was data on ophthalmology 32 and dermatology 57 from Germany, which showed a decrease in the number of cases for certain diagnoses, probably due to a shift of these services to outpatient care. In contrast, in the case of ophthalmology, reimbursement increased overall, likely due to the treatment of more complex cases. 32 A study on sepsis in neonates found a constant number of cases from 2001 to 2004. 44 At the same time, indicators for possible upcoding were reported. For example, it was found that birth weight was coded more often just below the threshold of a less well-remunerated DRG code. 24, 37 The aforementioned study on sepsis cases in neonates did not find any indication for upcoding with regard to birth weight in neonates. 44 In bigger and more specialized centers, hospitals with higher case numbers in the beginning tended to increase their case numbers faster. 43, 46 Fewer studies investigated the effect of DRG introduction on health care professionals, their working environment, and consequences for their decision making. Almost all of these studies were surveys among health care professionals, and they mainly found that professionals were ambiguous with regard to DRG and felt a considerable increase in economic pressure. 18, 30, 39, 47, 59 A survey among patients did not reveal a decisive impact of DRG on patient satisfaction. 48 The quality of inpatient care, according to national quality indicators, improved in German hospitals during the initial period after DRG introduction (2004-2008).
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Some studies directly compared reimbursement under DRG with reimbursement before DRG. Several studies found decreasing reimbursement per case over time. 29, 41, 42, 45, 49, 58 The decrease in reimbursement could be explained by the consecutive reduction in LOS, suggesting that reimbursement adapted to the lower length of stay.
Some examples of unfortunate results of DRG introduction were also shown, ie, examples where DRG provided wrong incentives. First, one publication pointed out a particular problem of undesired effects: Futile therapy at the end of life was rewarded by higher DRG reimbursement, and financial benefit for the hospital increased when end-of-life decision was delayed. 50 Second, a cost analysis revealed that elective patients without complications were better reimbursed under DRG. 54 
| DISCUSSION
Similar to previous reviews, 10, 15 we found a limited number of studies evaluating the effects of DRG based on empirical data, and none of them were randomized controlled trials. The included empirical studies included a variety of specialties and outcome parameters. More than two-thirds of reviewed studies were not based on empirical data, and instead presented personal opinions, assumptions, or secondary analysis of the limited amount of available data in reviews. This indicates that the scientific discussion on the topic is largely based on subjective assessment of the situation and far from entirely evidence-based.
Data collection and analysis was homogenously quantitative. A majority of these studies used routine data from patient records, hospital reports, or superordinate institutions. Many studies collected data over the years and analyzed them for longitudinal changes. Comparison over the years is problematic in the case of DRG because the health care system is constantly affected by new developments, such as demographic and epidemiologic changes, technological progress, medical innovations, as well as specialization of medical, therapeutic, and care activities. All these changes result in a high risk of bias for studies comparing consecutive data.
As stated previously, 10, 16 results and conclusions of the existing studies do not provide a clear indication if DRG introductions in the two countries have had positive or negative impacts on patient care. However, DRG was not introduced to increase the quality of care as its primary goal. The predominant aim of DRG is to contain health care
expenditure without changing quality of care. Within the considered articles, there was no concrete evidence that quality of care was adversely affected by the introduction of DRG considering indicators such as mortality or rehospitalization. On the other hand, the empirical results of the triad LOS (trend: decreased), reimbursement (stable or even increasing due to the combination of increased caseload and decreased LOS), and case numbers (trend:
increased) describe why the main goal to contain health cost expenditure was not attained by DRG introduction.
Indeed, a uniform decrease in LOS and consecutively in reimbursement per case was found in the included studies. At the same time, case numbers increased or cases were upcoded, which probably counterbalanced any overall positive economic effects. Freed-up resources could be used to increase the number of procedures and patients. This thwarts the desired cost containment and, more dangerously, might increase overdiagnosis and overtreatment. Comparing health care expenditure for Germany and Switzerland before and after DRG introduction shows that costs are still rising in both absolute and relative sense with respect to the GDP. In Germany, the cost for hospitals rose from None of the included studies claimed transparency as an explicit outcome parameter, even though increasing transparency was one of the aims of introducing DRG. 4 One interpretation of increased transparency could be that it is obtained if routine DRG data are made available for research purposes, allowing analysis of nationwide cohorts and the comparison between different types of hospitals. However, even if that was the case, the availability of such data does not automatically lead to higher transparency. Nevertheless, it is evident that there are indicators, such as in the studies reporting upcoding in neonatology, 24, 37 that reality is sometimes adjusted to increase reimbursement.
Routine data based on DRG should therefore be analyzed with caution and not confounded with epidemiological data collected independently from financial incentives.
We did not systematically evaluate quality or risk of bias of empirical research on DRG, but we argue that its value might be limited due to several factors. Many studies were done shortly after the introduction of DRG. Thus, the few studies with parallel comparison groups covered limited periods of time and were all performed in Switzerland before the introduction of DRG became obligatory. 12, 13 To evaluate changes in the health care system is particularly difficult because many different changes occur simultaneously. Jauss et al describes the multiple changes in Germany that affect stroke patient care 11 : Provision of care for stroke patients substantially improved over the last two decades, which was also reflected in the comparative data analysis of registry data from 2003 to 2006. However, the association of these changes to the introduction of DRG is unclear.
A further particularity of DRG is that codes, cost weights, and respective instructions change over time. This is because DRG is meant to adapt to changes in health care. 4 Such integral changes result in a further bias when comparative studies are carried out. In addition, the implementation of DRG in Germany and Switzerland was sequential, which might further weaken the effects in the early phase of DRG introduction. In Switzerland, several versions of performance-based payment schemes existed already before the DRG introduction in 2012, 63 potentially confounding the simultaneous changes in health care and DRG introduction.
When comparing DRG data from the United States with our data found for Germany and Switzerland, it is important to note that changes upon DRG introduction partly depend also on the way health care was financed previously.
This leads to the finding that DRG introduction increased activity in Europe, while data from the United States show a decrease of activity after the introduction in the 1980s. 64 
| CONCLUSION
No empirical evidence was found that clearly indicates positive or negative effects of DRG introduction on patient care, case numbers/distribution, health professionals, patient satisfaction, or reimbursement. In many cases, it is probably impossible to evaluate DRG introduction independently from other developments in the health care system.
The demonstrated decrease in LOS can be either positive or negative for the patients and health system as a whole.
Caution should be taken on the DRG system incentive to increase case numbers and maximize overall reimbursement in order to avoid overdiagnosis and overtreatment. Further research is also necessary to guide policymakers on how to best achieve the desired cost containment and thereby the sustainability of the overall health care system.
ACKNOWLEDGEMENT
We thank Brian Cheng for final language revision.
CONFLICT OF INTEREST
None.
FUNDING OR SOURCES OF SUPPORT IN THE FORM OF GRANTS, EQUIPMENT, DRUGS, ETC.
This paper presents results from the project "Inpatient-outpatient transition in the era of DRGs: the legal framework and current practice" (Nr. 156274) funded by the Swiss National Science Foundation.
ETHICAL APPROVAL
This study is exempt. No human or animal subjects were included.
ORCID
Insa Koné http://orcid.org/0000-0002-4979-584X
